Multicenter evaluation of a new automated fourth-generation human immunodeficiency virus screening assay with a sensitive antigen detection module and high specificity

Journal of Clinical Microbiology

Volumn 40, Issue 6, 2002, Pages 1938-1946

  Weber, Bernard ^a   Gürtler, Lutz ^a   Thorstensson, Rigmor ^a   Michl, Ulrike ^a   Mühlbacher, Annelies ^a   Bürgisser, Philippe ^a   Villaescusa, Roberto ^a   Eiras, Adolfo ^a   Gabriel, Christian ^a   Stekel, Herbert ^a   Tanprasert, Srivilai ^a   Oota, Sinenaart ^a   Silvestre, Maria Jose ^a   Marques, Cristina ^a   Ladeira, Maria ^a   Rabenau, Holger ^a   Berger, Annemarie ^a   Schmitt, Urban ^a   Melchior, Walter ^a  

^a Lab R Kutter Lieners Hastert Ctr   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ANTIGEN DETECTION; ARTICLE; AUTOMATION; CELL CULTURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

AIDS SERODIAGNOSIS; BLOOD DONORS; HIV ANTIBODIES; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; IMMUNOENZYME TECHNIQUES; MASS SCREENING; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0036262946     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.6.1938-1946.2002     Document Type: Article

References (36)

1. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions
2. Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood
3. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results
4. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
5. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors
6. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections
7. False negative anti-HIV-1/HIV-2 ELISAs in acute HIV-2 infection
8. Unsuspected primary human immunodeficiency virus type I infection in seronegative emergency department patients
9. Serologic tests for the retroviruses: Approaching a decade of evolution
10. Tests de dépistage combiné des anticorps anti-VIH et de l'antigène p24
11. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay
12. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon
13. HIV type 1 V3 serotyping of Tanzanian samples: Probable reasons for mismatching with genetic subtyping
14. The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence and nomenclature: W. H. O. network for HIV isolation and characterization
15. Heterogeneity of HIV-1 and HIV-2
16. Direct HIV testing in blood donations: Variation of the yield with detection threshold and pool size
17. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing
18. Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays
19. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection
20. Immune response to HIV p24 core protein during early phases of human immunodeficiency virus infection
21. Redefining the HIV-infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission
22. Multicenter evaluation of the new HIV DUO assay for simultaneous detection of HIV antibodies and p24 antigen
23. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence
24. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood bank setting
25. Fourth-generation enzyme linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody
26. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptide serotyping and its relation to sequence analysis
27. Identification of a new human immunodeficiency virus type 1 distinct from group M and Group O
28. Detection and subtyping of HIV-1 isolates with a panel of characterized monoclonal antibodies to HIV p24 gag
29. Improved performance in seroconversion with a 4th generation HIV antigen/antibody assay
30. Strongly enhanced sensitivity of a direct anti-HIV-1/-2 assay in seroconversion by incorporation of HIV p24 Ag detection: A new generation vironostika HIV Uni-Form II
31. Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra
32. Reduction of diagnostic window by new fourth-generation human immunodeficiency virus screening assays
33. Multicenter evaluation of a new rapid automated HIV antigen detection assay
34. Early diagnosis of primary HIV infections: Using a combined screening test (p24 antigen and anti-HIV antibodies)
35. Early detection of antibodies to HIV-1 by third-generation assays